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Abstract
Background: It is known that HIV-1 protease is an important target for design of antiviral compounds in the treatment of
Acquired Immuno Deficiency Syndrome (AIDS). In this context, understanding the catalytic mechanism of the enzyme is of
crucial importance as transition state structure directs inhibitor design. Most mechanistic proposals invoke nucleophilic
attack on the scissile peptide bond by a water molecule. But such a water molecule coexisting with any ligand in the active
site has not been found so far in the crystal structures.
Principal Findings: We report here the first observation of the coexistence in the active site, of a water molecule WAT1,
along with the carboxyl terminal product (Q product) peptide. The product peptide has been generated in situ through
cleavage of the full-length substrate. The N-terminal product (P product) has diffused out and is replaced by a set of water
molecules while the Q product is still held in the active site through hydrogen bonds. The position of WAT1, which
hydrogen bonds to both the catalytic aspartates, is different from when there is no substrate bound in the active site. We
propose WAT1 to be the position from where catalytic water attacks the scissile peptide bond. Comparison of structures of
HIV-1 protease complexed with the same oligopeptide substrate, but at pH 2.0 and at pH 7.0 shows interesting changes in
the conformation and hydrogen bonding interactions from the catalytic aspartates.
Conclusions/Significance: The structure is suggestive of the repositioning, during substrate binding, of the catalytic water
for activation and subsequent nucleophilic attack. The structure could be a snap shot of the enzyme active site primed for
the next round of catalysis. This structure further suggests that to achieve the goal of designing inhibitors mimicking the
transition-state, the hydrogen-bonding pattern between WAT1 and the enzyme should be replicated.
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Introduction
Human Immunodeficiency Virus (HIV) is the causative agent of
Acquired Immunodeficiency Syndrome (AIDS) [1,2]. Inhibitors of
the viral enzyme HIV-1 protease (EC 3.4.23.16) are important
components of Highly Active Anti Retroviral Therapy (HAART)
for HIV/AIDS [3,4]. The emergence of mutants of HIV-1
protease resistant to inhibitor action necessitates continuous
improvement of existing drugs and also of design of new inhibitors.
Understanding the catalytic mechanism and the structure and
interactions of the transition state would contribute significantly in
the development of novel inhibitors. Based on computational
[5–8], biochemical [9–11] and structural results [12–16], two types
of proposals have been made in the past for the catalytic
mechanism: direct and indirect [reviewed in 17–18]. In the direct
type, championed mostly by computational studies, the nucleo-
philic attack on the carbonyl carbon atom of the scissile peptide
bond is directly by carboxyl oxygen atom of the catalytic
aspartates. In the indirect type, the attack is by a water molecule
[19]. The position and hydrogen bonding patterns from this water
molecule at the time of attack are different in different proposals of
the catalytic mechanism, and therefore knowing the location and
interactions of nucleophilic water molecule would be a step in
establishing the correct mechanism for this enzyme.
HIV-1 protease is a homodimeric enzyme in which the active
site is located at the subunit interface, with each subunit
contributing one aspartic acid to the catalytic center. The active
site is covered on the top by two flaps, which become ordered into
a closed conformation whenever a substrate or inhibitor is bound
in the active site. During virus maturation, HIV-1 protease cleaves
viral polyproteins at nine different sites of varying amino acid
sequences. A water molecule found symmetrically hydrogen
bonded to carboxyl oxygen atoms of both catalytic aspartates in
the high resolution crystal structures of unliganded enzyme, (PDB
Id 1LV1 and 2G69) is believed to be the nucleophile. This belief
has been questioned [20] recently on the grounds that in the
crystal structures of enzyme-ligand complexes, this water molecule
has not been found to coexist with the ligand. Thus the location of
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open question. In this respect, we have been pursuing crystallo-
graphic studies on active HIV-1 protease complexed with different
substrate peptides [21–23]. We have been able to carry out such
studies because of our discovery of closed-flap conformation of the
enzyme in hexagonal crystals of HIV-1 protease even when the
enzyme is unliganded [24–25]. Complexes with oligopeptide
substrates could then be prepared by soaking these native crystals
into aqueous solutions of the substrates. The chemical conditions,
pH for example, of these solutions could be varied to try trapping
the reactants at different stages of the reaction. In the present
study, native crystals were soaked into solution of the substrate of
amino acid sequence His-Lys-Ala-Arg-Val-Leu*-NPhe-Glu-Ala-
Nle-Ser (where * denotes the cleavage site and NPhe & Nle denote
p-nitrophenylalanine and norleucine, respectively) at pH 7.0. It
was found that the full length substrate was cleaved at the specific
cleavage site (Leu-p-nitro-Phe). The N-terminal product peptide (P
product) had diffused out leaving behind only the C-terminal
product peptide (Q product) still bound in the enzyme active site.
A set of water molecules had moved into the region vacated by the
P product peptide. One of these water molecules (WAT1) is
optimally positioned to be the nucleophile. In this position, the
water molecule does not accept any hydrogen bond through its
lone pair and also is a donor in two strong hydrogen bonds, two
features that contribute significantly towards activation of the
water molecule for nucleophilic attack [26]. This position is shifted
by about 1.4 A ˚ from that observed in all unliganded structures of
HIV-1 protease. The position WAT1 overlaps exactly the
hydroxyl group of the picomolar transition-state mimic inhibitor
KNI-272. Adachi et al. have suggested this hydroxyl oxygen of
KNI-272 to be an ideal position for a water molecule to launch
nucleophilic attack on the scissile peptide bond [27]. Thus the
present report of HIV-1 protease product complex is the first
observation of putative catalytic water coexisting with the product
peptide. This structure further suggests that the transition-state-
mimics, such as KNI-272, should be so designed that they bind the
catalytic aspartates with a hydrogen-bonding pattern similar to
that of WAT1.
Results
The Model of the complex
HIV-1 protease tethered dimer used here contains a five residue
linker, GGSSG, linking the N-terminus of second monomer to C-
terminus of the first monomer [28]. Residues in the first monomer
are numbered as 1–99 and those in the second monomer are
numbered 1001–1099. Residues of the linker are numbered as
101–105. Crystal and intensity data statistics are given in Table 1.
On refinement of the protein structure, difference density was
found in the active site region of the enzyme (Figure 1), and this
difference density represented the soaked-in substrate cleaved at
the linkage connecting Leu and Nphe residues in the sequence. As
per convention, residues in the C-terminal product (Q product)
counted from the scissile bond were designated as P1’–P5’, and
those in the N-terminal product (P product) as P1–P6. The density
for residues P1–P6 was very weak suggesting that the P product
peptide had diffused out leaving behind only the Q product
peptide still bound in the enzyme active site. A set of water
molecules had substituted the P product peptide. Electron density
for residues beyond P2’ in the Q product was also very weak. The
Q product and the water molecules were placed in two
orientations, consistent with the pseudo-symmetry of HIV-1
protease active site. The lowest Rfree was obtained when the
occupancies for the two orientations were 0.7 and 0.3. The B-
factor averaged over all atoms of the product peptide was 43.7 A ˚ 2
and 42.2 A ˚ 2 respectively for the two orientations. The electron
density suggested that the side chains of few protein residues
existed in multiple conformations in the crystal. Alternate
conformations were modeled for the residues Val 82, Ile 84, Val
1082 and Ile 1084. There was no visible density in the 2Fo-Fc map
for the linker region between residues 99 and 1001 of the tethered
dimer under study, suggesting that the linker region was not
ordered in the crystal. The final molecular model thus consisted of
1514 protein atoms, 181 water molecules and Q product peptide
bound in two orientations with occupancies of 70% and 30%
respectively. Conformationally, more than 90% of non-glycine
residues were in the most favored regions of Ramachandran plot.
The final refined 2Fo-Fc map for P1’ p-nitro-phenylalanine and
P2’ glutamic acid residues and the active site water molecules in
the two orientations are shown in Figure 2.
Protease- Q Product peptide interactions
Hydrogen bonding interactions between P1’, P2’ residues of the
Q product and the protein residues in the active site are shown in
Figure 3a. The Q product is held in the active site through 11
hydrogen bonds, some of which are through bridging water
Figure 1. Difference density in the active site of HIV-1
protease/product complex. The enzyme is shown as a Ca trace.
The side chains of catalytic aspartates are also drawn.
doi:10.1371/journal.pone.0007860.g001
Table 1. Data collection and refinement statistics.
Space group P61
Unit cell parameters (A ˚) a=b=62.54,c=81.99
Wavelength used (A ˚) 0.97945
Resolution (A ˚) 1.69 (1.72–1.69)*
Number of unique reflections 20251 (922)*
I/s(I) 12.61 (3.35)*
Rmerge (%) 8.2 (49.0)*
Completeness (%) 97.9 (94.1)*
Refinement statistics
Rwork/Rfree (%) 21.9 (30.2)*/25.6 (31.5)*
RMS deviations from ideal values
Bond lengths (A ˚) 0.01
Bond angles (u) 1.5
*Data for highest resolution shell are given in the parenthesis.
doi:10.1371/journal.pone.0007860.t001
HIV-1 PR and Catalytic Water
PLoS ONE | www.plosone.org 2 November 2009 | Volume 4 | Issue 11 | e7860Figure 2. Fit of carboxy terminal product peptide and active site water molecules into 2Fo-Fc electron density. The electron density
map is contoured at 1.0s level. The carboxyl product peptide ( violetpurple) and the active site water molecules are shown in the two orientations.
doi:10.1371/journal.pone.0007860.g002
Figure 3. Hydrogen bonding interactions at the active site: a) between the protease and the P1’–P2’ residues of the Q product peptide, b)
between the protease and the water molecules. Possible hydrogen bonds are drawn as dotted lines, and the lengths are indicated.
doi:10.1371/journal.pone.0007860.g003
HIV-1 PR and Catalytic Water
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orientations forms hydrogen bond to the outer oxygen (OD2) of
ASP- 1025/ASP- 25 (Figure 3a). The side chain of P2’ GLU forms
hydrogen bonds with main chain amide nitrogen and side chain
carboxyl oxygen of ASP- 30 or ASP- 1030 depending upon the
orientation. One very well ordered water molecule forms the
bridge between product peptide and the amide group of Ile 50/Ile
1050. One of the oxygens of P1’ nitro group forms hydrogen bond
with the Arg 8 while the other oxygen is bridged by two water
molecules to the carbonyl oxygen of Gly 49.
Water molecules in the active site
A set of water molecules had substituted the P product peptide.
These water molecules are held in place through hydrogen bonds
among themselves and also with the protein (Figure 3b). One of
these water molecules, WAT1, which is within hydrogen bonding
distance from the oxygens of both catalytic aspartates, may be of
functional importance. The OMIT density for this water molecule
is shown in Figure 4. WAT1 also makes a short hydrogen bond
with the N-atom of the Q product peptide. WAT1 is shifted by
about 1.4 A ˚ from the corresponding water molecule coordinating
both catalytic aspartates in the unliganded structures (PDB Id
1LV1 and 2G69). This water molecule is at an average distance of
about 2.7 A ˚ from the scissile carbon of the modeled substrate
peptides (Figure 4).
Discussion
Position of attacking water molecule
In the hydrolysis reaction catalyzed by HIV-1 protease there are
two substrates: 1) an oligopeptide of appropriate amino acid
sequence and 2) the nucleophilic water molecule. At the start of
the reaction, both these are bound in the active site leading to
formation of Michaelis complex. At the end of the reaction, but
before product release, the nucleophilic water is used up and
hence should not be present in the active site. The presence of
WAT1 in the active site places the present structure somewhere
near the beginning steps of the reaction. Presently there is no
crystal structure report of a Michaelis complex between active
HIV-1 protease and substrate peptide. However, the present
structure can be considered a close approximation to Michaelis
complex since a part of the substrate peptide is present in the
active site along with the water molecule. We have earlier reported
the structures of HIV-1 protease complexed with two different
substrate oligopeptides corresponding in amino acid sequence to
the junctions RH-IN [21] and RT-RH [22] in the polyprotein
substrate. While the substrate is converted into a tetrahedral
intermediate in the complex with RH-IN, the RT-RH peptide is
cleaved, with both product peptides still bound in the active site.
The water molecule, WAT1, is at a distance of 0.9 A ˚ from one
gem-diol hydroxyl in the tetrahedral intermediate complex.
Similarly WAT1 is at a distance of about 1.0 A ˚ from one of the
carboxyl oxygens in the product peptide complex (PDB Id 2NPH)
(Figure 5). Because of these proximities, we suggest that the water
molecule serving as the nucleophile in peptide bond hydrolysis
does so from the position WAT1 observed in the present structure.
Such a hypothesis would be consistent with the principle of least
nuclear motion for chemical reactions [29]. To further explore this
idea, we have investigated by molecular modeling, if the scissile
peptide bond of a substrate bound in the active site would be
accessible to WAT1 for attack. We have superposed separately the
present complex with reported complexes between D25N inactive
enzyme and two different substrate oligopeptides (PDB Id 1KJH
and 3BXR) [30,31]. Using only protein Ca atoms for structural
superposition, equivalent positions of the substrate molecules were
derived. Figure 4 shows the derived positions relative to WAT1. It
is clear that the scissile peptide bond is optimally accessible to
WAT1 for nucleophilic attack, the WAT1…C-O and WAT1…C-
N angles being 69u and 104u respectively. Further, the distance of
WAT1 to the scissile carbon atom is 2.7 A ˚, which is reasonable for
a nucleophilic attack. Figure 4 also shows the position of the
catalytic water observed in the structure of unliganded HIV-1
protease (PDB Id 1LV1). The separation of this water molecule
from the scissile carbon atom is only 1.9 A ˚, which is too short a
distance for the water molecule to stay in this position along with
the substrate. Unlike in unliganded structures, the position of
WAT1 is asymmetric with respect to the catalytic aspartates.
WAT1 forms two short hydrogen bonds to outer and inner
carboxyl oxygens of ASP- 25 and ASP-1025 respectively. Further,
WAT1 does not accept any hydrogen bond and is a donor (see
below) in two strong hydrogen bonds with catalytic aspartates.
Both these features should increase the nucleophilicity of WAT1
[26]. From all these considerations, WAT1 appears to be a
reasonable position for the water molecule from where nucleo-
philic attack takes place during bond breakage. This hypothesis is
also consistent with the structure of HIV-1 protease/KNI-272
complex reported recently [27]. KNI-272 is one of very few highly
selective and potent inhibitors of HIV-1 protease with a picomolar
inhibitory constant. The high potency is suggested to be due to its
pre-organized rigid structure that very closely resembles the
transition state. The structure of the complex has been determined
to very high resolution using X-ray and neutron diffraction
techniques. According to the authors of this study, the position of
the hydroxyl group in the hydroxymethylcarbonyl part of KNI-
272 is ideal to mimic the location of the attacking water molecule
in catalysis. Figure 6 shows the superposition of the present
Figure 4. Relative positions of WAT1 and the modelled
substrate in the active site: Diagram showing superposition of
three structures: 1) present structure (yellow carbon), 2) unliganded
HIV-1 protease (magenta carbon, PDB Id 1LV1) and 3) inactive HIV-1
protease/substrate complex (green carbon, PDB Id 1KJH). Water
molecule observed in unliganded HIV-1 protease is also shown
(magenta). The distances to the scissile carbon atom are indicated. SA
OMIT density contoured at 3s level is also shown for WAT1.
doi:10.1371/journal.pone.0007860.g004
HIV-1 PR and Catalytic Water
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above (PDB Id 3FX5). It is very interesting that WAT1 perfectly
overlaps the hydroxyl group of KNI-272 in the complex. Since this
overlap guarantees the adherence to the principle of least nuclear
motion, KNI-272 is a very potent inhibitor of HIV-1 protease. In
addition to hydrogen bonds to catalytic aspartates, WAT1 is
hydrogen bonded to the terminal N atom of the Q product
peptide. Once the Q-product leaves the active site, WAT1 will
move back to the position observed in the structures of unliganded
HIV1-protease. The relative positions of the substrate, nucleophile
and catalytic aspartates at different stages of the cleavage reaction,
according to our proposal, are shown in Figure 7 (a–f).
Figure 5. Structural comparison of present complex with tetrahedral intermediate complex [21] and product peptide complex [22]:
Stereo diagram showing the ligand atoms at the catalytic centre along with catalytic aspartates. Protein Ca atoms are used in the structural
superposition. WAT1 is within 1 A ˚ from an oxygen atom in the newly generated gem-diol [21] or carboxyl group [22].
doi:10.1371/journal.pone.0007860.g005
Figure 6. Position of the nucleophilic water molecule. Stereo diagram showing the overlap between the hydroxyl group (red) of transition-
state mimetic inhibitor KNI-272 and WAT1 (cyan) of the present structure. The Q product peptide of the present structure is not shown. Note the
perfect overlap of WAT1 and the hydroxyl oxygen of KNI-272.
doi:10.1371/journal.pone.0007860.g006
HIV-1 PR and Catalytic Water
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In the process of inhibitor design, it is important to both
structurally mimic the transition state intermediate and to
maximize interactions between the inhibitor and the catalytic
aspartates. In this context, it is essential to know the protonation
states of the catalytic aspartates so that appropriate functional
groups are chosen in the inhibitor being designed. Even though
hydrogen atoms are not located in the present study, the observed
strong hydrogen bonds involving the catalytic aspartates provide a
clue to the protonation states of the aspartates. Only O—O/N
separation shorter than 2.8/2.9 A ˚ are considered as definite
hydrogen bonds [32]. There are four such distances at the catalytic
centre in the present structure: i) ASP-25 OD1…ASP-1025 OD1,
ii) WAT1… ASP-25 OD1, iii) WAT1…ASP-1025 OD2 and iv)
ASP-1025 OD2…N-terminus of P1’ residue. The angle ASP-25
OD2 –WAT1- ASP-1025 OD1 is 101u which is very close to the
H-O-H angle (104u) in a water molecule indicating that in the
hydrogen bonding to the water molecule WAT1, the aspartate
oxygens act as acceptors. Since the substrate is already cleaved, N-
terminus of P1’ residue is already protonated and it would be a
donor in the hydrogen bond with ASP-1025 OD2 atom. Thus the
aspartic dyad is monoprotonated with the proton shared between
inner oxygens of the two aspartates. We therefore suggest that just
prior to the formation of the transition state the aspartates are
in this state of protonation. Since on inhibitor binding the
protonation state is not likely to change, the hydrogen-bonding
group should be chosen appropriately on the inhibitor to
maximize interactions with aspartates in this state of protonation.
Effect of pH on conformation and interactions from ASP-
25 and ASP-1025
HIV protease is known to be active over a wide range of pHs. In
our earlier study of the crystal structure of HIV-1 protease
complexed with the undecapeptide substrate (His-Lys-Ala-Arg-
Val-Leu*-NPhe-Glu-Ala-Nle-Ser) at a pH value of 2.0, the
substrate bound in the active site had transformed into a
tetrahedral intermediate through nucleophilic attack by a water
molecule [21]. In contrast, in the present study carried out at
pH 7.0, the substrate molecule of the same sequence is found
cleaved at the correct scissile bond, and the N-terminal P product
peptide has diffused out of the enzyme active site. The
conformations and interactions of the catalytic aspartates at the
two pHs are compared in Tables 2 and 3. The changes in the
conformations around main-chain and side-chain torsions of the
two aspartates are very small, but these small changes have
synergistically caused differences in the interaction distances,
which could be significant. The hydrogen bonds from inner
oxygen (OD1) atoms to N atom of corresponding Gly-27/1027
residues have become longer for both aspartates at pH 7.0. The
distance between the two inner oxygen atoms, on the other hand,
has changed in the opposite direction, that is, to shorter value, at
pH 7.0. If the length of a hydrogen bond is assumed to reflect its
strength, the changes in lengths mentioned above appear to
preserve the total hydrogen-bonding ability of each OD1 atom.
There is a significant change in the virtual dihedral angle OD2
(25)-OD1 (25)-OD1 (1025)-OD2 (1025), which is a measure of the
co-planarity of the two aspartic acid side chains [15]. The two side
chains tend toward being more co- planar at pH 7.0. There also
appears to be a correlation between the co-planarity of the two
aspartates and the strength of the hydrogen bond between the
OD1 atoms of catalytic aspartates; the higher co-planarity leading
to stronger hydrogen bond. In the structure of HIV-1 protease
product complex [22] determined at a pH of 6.2 the aspartates are
more co-planar with a virtual dihedral angle of 22u while the
OD1..OD1 distance of the postulated hydrogen bond is only
2.3 A ˚.
Product release
The patterns of product inhibition are dependent on the
enzyme mechanism. Based on product inhibition and solvent
isotope effects, in the cleavage reaction by HIV-1 protease the
product peptides are proposed to be released in an ordered
manner, with the P product peptide released first [11]. The
presence of only carboxyl terminal product in the present structure
is consistent with this expectation. The Q product peptide is
Figure 7. Proposed sequence of steps (a–f) in the cleavage of peptide bond by HIV-1 protease. Only main chain atoms of substrate
peptide (green carbon) are shown. Each figure is based on the structure indicated: (a) catalytic water molecule bound symmetrically to the two
aspartates (structure PDB Id 1LV1), (b) movement of catalytic water to position WAT1 with binding of substrate (modelled), (c) attack by WAT1 and
formation of tetrahedral intermediate (Structure TI), (d) cleavage of the peptide bond with product peptides still bound in the active site (structure
PDB Id 2NPH), (e) diffusion of P product out of and WAT1 into active site (present structure), and (f) release of Q product and movement of WAT1 into
original position (PDB Id 1LV1).
doi:10.1371/journal.pone.0007860.g007
Table 2. Comparison of conformation of catalytic aspartates
in the structures at pH 2.0 and pH7.0.
Parameter compared pH x1 (u) x2(u) W(u) Y(u)
Conformation of Residue ASP-25 2.0 2173 225 2126 285
7.0 2171 214 2120 286
Conformation of Residue ASP-1025 2.0 2175 166 2116 284
7.0 2173 173 2121 283
doi:10.1371/journal.pone.0007860.t002
HIV-1 PR and Catalytic Water
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the distance between Ca atom of P1’ residue and Cc atom of distal
aspartate has increased from 5.0 A ˚ in the tetrahedral intermediate
structure [21] to 5.5 A ˚ in the present structure (Figure 5). It is
interesting that it is the N-terminal P product which is bound
when active HIV-1 protease is cocrystallised with a constrained
hexapeptide [31]. This difference may be due to the different
approach taken for preparing crystalline enzyme/substrate
complex. The constrained hexapeptide is cleaved during cocrys-
tallisation, and from among the two products released into solution
the P product is selectively bound in the active site because of its
increased hydrogen bonding ability coming from the newly formed
carboxyl group. Similarly, on cocrystallisation, the presence of an
amino group in the product peptide PIV-CONH2 resulted in
binding of PIV-CONH2 in the active site of HIV-1 protease, in an
unexpected mode [13,31].
Conclusion
Native crystals of active tethered HIV-1 protease were soaked in
an undecapeptide substrate solution at pH 7.0. Three dimensional
crystal structure, determined to 1.69 A ˚ resolution shows that the Q
product peptide generated within the crystal is still bound in the
active site of HIV-1 protease along with a set of water molecules.
One of these water molecules, WAT1, which is activated through
hydrogen bonds to catalytic aspartates, is located at a distance of
2.7 A ˚ along the direction perpendicular to the scissilepeptide bond.
Assuming the present structure to be a close approximation to
Michaelis complex, we propose that the incoming substrate pushes
the nucleophilicwater from the position observedin the unliganded
protease to the WAT1 position from where it attacks the scissile
peptide bond. Once the Q product also diffuses out, the catalytic
water molecule can move back to the position observed in
unliganded structures of HIV-1 protease. Comparison of geome-
tries at the catalytic centre shows systematic changes in the
conformationand interactionsofcatalytic aspartates at pHs2.0 and
7.0. The structure reported here also suggests that in the design of
effective inhibitors of HIV-1 protease, it is important to duplicate
the hydrogen-bonding pattern of WAT1 with catalytic aspartates.
Materials and Methods
Protein expression, crystallization and soaking
HIV-1 protease tethered dimer used in the present study
contains a five residue linker, GGSSG, covalently linking the two
monomers [28]. Expression, purification and crystallization of
HIV-1 protease tethered dimer followed the procedures reported
earlier [24–25]. Briefly, BL21 (DE3) cells with HIV-1 protease
tethered dimer insert carrying plasmid were grown at 37uCt oa n
O.D600 of 0.6. The protease expression was induced by adding
1mM IPTG. Two hours after induction, cells were harvested and
lysed using sonication to prepare the inclusion bodies. Inclusion
bodies were thoroughly washed with Tris EDTA buffer and
protein was extracted in denatured form with 67% acetic acid.
Extract was diluted and dialyzed overnight against water. This was
followed by dialysis against refolding buffer of pH 6.5, containing
20mM PIPES, 100mM NaCl, 1mM dithiothreitol and 10%
Glycerol.
The cloned insert contains 57 extra codons in the beginning,
which is a part of N-terminal polyprotein of pol gene. Therefore
the inserted gene product is a 29 kDa precursor protein,
containing natural cleavage site for HIV-1 protease, which after
self cleavage results in a mature protein of 22 kDa.
Crystals were grown by hanging drop vapour diffusion method.
Equal volumes of Protein (5 mg/ml in 50 mM sodium acetate,
pH 4.5, containing 1 mM dithiothreitol) and reservoir solution
(1% saturated ammonium sulfate, 200 mM sodium phosphate,
and 100 mM sodium citrate at pH 6.2) were mixed on a cover slip
and sealed over the reservoir well at room temperature.
The 11-residue substrate peptide of amino acid sequence His-
Lys-Ala-Arg-Val-Leu-NPhe-Glu-Ala-Nle-Ser was synthesized at
the National Institute for Research in Reproductive Health, Parel,
Mumbai, by using an automatic peptide synthesizer. The peptide
was dissolved in water to prepare a 5 mM stock solution. This
stock solution was diluted 5-fold into the reservoir solution
(pH 7.0) to prepare the soaking drop. Protease crystal was
transferred first to a fresh reservoir solution (pH 7.0) drop to
wash the crystal and then to the soaking drop using a cryoloop.
The cover slip was inverted and sealed over the same reservoir well
in which crystals had been grown.
X-ray data collection and refinement
At the end of 72 h of soaking at room temperature, the crystal
was equilibrated in the cryo-protectant (25% glycerol and 75%
reservoir buffer) before flash freezing, for exposure to X-rays on
the FIP-BM30A beam line [33]. The crystals diffracted to 1.69A ˚
resolution. The diffraction data were indexed, integrated, and
scaled by using the computer program XDS [34].
Computer program Phaser [35–36] from CCP4 suite was used
to obtain molecular replacement solution using the structure 1LV1
[25,37] as the search model. The structure was refined in
Crystallography and NMR System (CNS) by using standard
simulated annealing protocols and the amplitude-based maximum
likelihood target function [38–39]. A test set containing 5.0% of
randomly chosen reflections were reserved for determination of
Rfree [40], which is an indicator of gainful refinement. Occupan-
cies of ligand molecules in the two orientations were systematically
varied, in steps of 0.1, subject to the constraint that their sum be
1.0. Electron density maps of all types were calculated using CNS.
All interactive model building and molecular superpositions were
carried out using the graphics software O [41]. Structural
comparisons are based on superpositions of protein Ca atoms.
All figures were drawn using program Pymol [42]. Atomic co-
ordinates and structure factors have been deposited in the Protein
Data Bank under the PDB Id 2WHH.
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